Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Klara Best for: Outpatient practices that prioritize two-way patient messaging, telehealth, and intake forms in a communication-led patient experience
GLP-1 receptor agonists include semaglutide, liraglutide, and dulaglutide
Younis, but, overall, physicians must keep in mind that the welfare of the patient is the top priority
The fact that covering GLP-1s under Medicare Part D for authorized uses is already making a mark on total Part D program spending could be a sign of even higher spending to come as Part D plans are now able to cover Wegovy for its heart health benefits, and if new uses for GLP-1s are approved
When to Contact Your Provider Patients who have stopped tirzepatide should contact their GoalBMI Wellness provider if they experience: Significant weight regain particularly more than 5-10 lbs in the first few months after stopping Return of blood pressure, blood sugar, or cholesterol values that were previously improving on treatment Strong return of hunger or food cravings that are difficult to manage Questions about whether restarting tirzepatide or switching to a different medication is appropriate Difficulty maintaining dietary or lifestyle habits established during treatment Interest in a structured weight maintenance program with medical oversight You do not have to wait until significant regain has occurred before reaching out
